MEDCARE TECHNOLOGIES INC
8-K, 2001-01-10
SPECIALTY OUTPATIENT FACILITIES, NEC
Previous: FIBERNET TELECOM GROUP INC\, S-1/A, EX-23.3, 2001-01-10
Next: MEDCARE TECHNOLOGIES INC, 8-K, EX-10, 2001-01-10




                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 10, 2001

                           MedCare Technologies, Inc.
                           --------------------------
             (Exact name of registrant as specified in its charter)



         Delaware                        0-28790                 87-0429962B
         --------                        -------                 -----------
(State or other jurisdiction     (Commission File Number)     (IRS Employer
of incorporation                                             Identification No.)

1515 West 22nd Street, Suite 1210, Oak Brook, Illinois                 60523
------------------------------------------------------                 -----
         (Address of principal executive offices)                    (Zip Code)

Registrant's telephone number, including area code: (604) 659-5005


ITEM 1. Changes in Control of Registrant.

None.

ITEM 2. Acquisition or Disposition of Assets.

None.

ITEM 3. Bankruptcy or Receivership.

None.

ITEM 4. Changes in Registrant's Certifying Accountant.

None.

ITEM 5. Other Events.

     In a letter  agreement  dated January 4, 2001,  Harmel S. Rayat, a Director
and majority shareholder of MedCare  Technologies,  Inc., agreed to acquire 81.5
shares of the  Company's  convertible  preferred  stock  (par  value  $0.25) and
related warrants for $111,329 and 800,000  restricted common shares for $38,671.
The Company also granted Mr. Harmel S. Rayat 4,000,000  share purchase  warrants
to acquire common shares of the Company at $0.05 expiring  January 10, 2005. The
agreement also provided the Company  undertake to register all shares underlying
the Series B Convertible  Preferred  Stock and the share purchase  warrant.  The
agreement is attached as an exhibit.

<PAGE>

ITEM 6. Resignations of Registrant's Director's

None.

ITEM 7. Financial Statements and Exhibits.

None.

ITEM 8. Change in Fiscal Year.

None.

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                                      MEDCARE TECHNOLOGIES, INC.

                                                              By: /s/ Ray Krauss
                                                              ------------------
                                                     Ray Krauss, President & CEO

                                                          Date: January 10, 2001





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission